DESCRIPTIONActivated hepatic stellate cells (HSCs) play a major role in the development of liver fibrosis and their activation is the target of many anti-fibrotic therapies. However, these approaches have remained ineffective mainly due to an incomplete understanding of the molecular mechanisms underlying HSC activation and the lack of target specificity of candidate drugs. Features & ContactSign in and you'll be able to send enquiries about this item, view full details and save it
|